Transfer RNAs (tRNAs) are among the most heavily modified RNA species. Posttranscriptional tRNA modifications (ptRMs) play fundamental roles in modulating tRNA structure and function, and are being increasingly linked to human physiology and disease. Detection of ptRMs is often challenging, expensive and laborious. Restriction Fragment Length Polymorphism (RFLP) analyses study the patterns of DNA cleavage after restriction enzyme treatment; and have been used for the qualitative detection of modified bases on messenger RNAs. It is known that some ptRMs induce specific and reproducible base 'mutations' when tRNAs are reverse transcribed. For example, inosine, which derives from the deamination of adenosine, is detected as a guanosine when an inosine-containing tRNA is reverse transcribed, PCR-amplified and sequenced. ptRMdependent base changes on RT-PCR amplicons generated as a consequence of the reverse transcription reaction might create or abolish endonuclease restriction sites. The suitability of RFLP for the detection and/or quantification of ptRMs has not been studied thus far. Here we show that different ptRMs can be detected at specific sites of different tRNA types by RFLP. For the examples studied we show that this approach is able to reliably estimate the modification status of the sample, a feature that can be useful in the study of the regulatory role of tRNA modifications on gene expression.
INTRODUCTION
Transfer RNAs (tRNAs) are among the most heavily modified RNA species. Posttranscriptional modifications on tRNAs (ptRMs) may act as identity determinants for aminoacylation (e.g. posttranscriptional 5'-end guanosine addition on tRNA His is essential for tRNA charging); they can affect codon decoding by expanding or restricting codon recognition; or contribute to tRNA structure and stability 1 . In recent years ptRMs have become a strong focus of research, as mounting evidence points to roles for tRNA modifications in human pathologies such as cancer (e.g. 5-methylcytosine), diabetes (e.g. 2-methylthio-N6-threonylcarbamoyladenosine), neurological disorders (e.g. 5-methoxycarbonylmethyl-2-thiouridine), and mitochondrial-linked diseases (e.g. 5-taurinomethyluridine modifications on mitochondrial tRNAs), among others 2, 3 .
Unfortunately, the complex set of potential tRNA modifications makes their identification in any given tRNA extremely challenging.
Available methods for the analysis of posttranscriptional RNA modification include: i) radiolabeling of RNA species followed by selective RNA digestion with specific RNases, and analysis of migration patterns by 2D-thin-layer chromatography 4 ; ii) the use of liquid chromatography coupled to mass spectrometry (LC-MS/MS) 5, 6 ; and iii) methods that involve the reverse transcription (RT) of RNAs 7 . Additional methods have also been developed to study specific modifications such as the PHA6 assay in which isopentyl-N 6 -A37 can be detected based on the differential hybridization of an oligonucleotide against the anticodon loop of tRNAs carrying the modification 8 ; or the acryloylaminophenylboronic (APB) acid-based boronic affinity electrophoresis to detect queuosine modifications on tRNAs 9 .
Methods based on radiolabeling or mass spectrometry are usually laborious, low-throughput, and require specialized and expensive laboratory equipment and facilities. These methods may not be easily applied to study ptRMs on specific tRNA residues, or to monitor physiological levels of endogenous ptRMs in vivo. In addition, RNA samples need to homogeneous, in some cases large amounts of starting material is required, and a specific expertise on experimental optimization and data interpretation is often necessary. Therefore, there is still a need for developing novel techniques for ptRM detection that would overcome some of these limitations.
During RT, modified RNA bases may be either read by the reverse transcriptase as if unmodified, as a different base (resulting in a change in the resulting DNA sequence), or may block the advance of the reverse transcriptase causing an arrest in the transcript. These possible outcomes of the RT reaction are dependent on the nature of the RNA modification 7 . Restriction
Fragment Length Polymorphism (RFLP) is a technique that studies the patterns of DNA cleavage after restriction enzyme treatments 10 . It has been widely used in the past as a medium-to highthroughput technique to detect genetic polymorphisms, define DNA marker loci, perform genome mapping or gene tagging, and to construct genomic linkage relationships in human pedigrees 11 .
More recently, RFLP has been used to detect editing events on messenger RNAs such as adenosine-to-inosine (A-to-G mutation on the PCR product) and cytidine-to-uridine (C-to-T mutation on the PCR product) modifications [12] [13] [14] ; confirming that cDNA mutations caused by the reverse transcriptase can generate or abolish endonuclease restriction sites on PCR amplicons.
DEVELOPMENT OF THE METHOD
We envisaged that RFLP could be used to study ptRMs (Figure 1) . Analyses of small-RNAseq data in search for mutated sites that are distinguishable from simple base-calling errors have proven useful to map several different ptRMs at genomic scale [15] [16] [17] [18] ; suggesting that several ptRMs induce the incorporation of alternative nucleotides in the generated cDNA when the reverse transcriptase reads a modified tRNA. In the past, we validated these findings by using smallRNAseq to monitor the levels of inosine modifications on tRNAs in human cell lines 19 . Pseudouridine and Dihydrouridine are derived from Uridine. 5-Methylcytidine is derived from Cytidine.
In this context, RFLP could be beneficial because, by avoiding the need of performing RNA sequencing, it would allow detection of inosine and other ptRMs in standard laboratory facilities, rapidly, and in a cost-effective manner. The RFLP method to detect ptRMs that we present here has four simple steps: RT, PCR amplification with specific primers, incubation of the PCR product with a specific restriction enzyme, and detection of the cleavage patterns by standard gel electrophoresis ( Figure 2) . Here, we have applied this method to study different ptRMs in different tRNA types, using in vitro and in vivo tRNA samples. We additionally show direct applications of the method to study, for example, the activity of a tRNA modification enzyme in vitro, or to monitor the levels of ptRMs in vivo. We believe that this method offers a new and useful approach to the detection and study of tRNA modifications. the reverse transcriptase reads I34 as a G and incorporates a C on the cDNA strand. Therefore, after PCR amplification, the original I34 position is read as a G34. The obtained amplicon is then digested with a specific restriction enzyme that would recognize and cleave the target in a modified/unmodified residue-dependent manner. The products of digestion are then resolved by gel electrophoresis and the proportion of cleaved:uncleaved amplicon can be quantified to estimate the levels of modified tRNA.
VALIDATION OF THE METHOD
Detection of inosine from in vitro tRNA samples. As a proof of concept, we first decided to apply the RFLP method to in vitro tRNA samples, and to focus on inosine detection (Figure 1 ).
Inosine is present at the first position of the anticodon (position 34; 'wobble' position) of bacterial tRNA Arg ACG and 7-8 eukaryotic tRNAs. It is the result of a deamination reaction of adenosine, catalyzed in eukaryotes by the heterodimeric adenosine deaminase acting on tRNAs (hetADAT).
Inosine is one of the few essential ptRMs described, as it is required to expand the number of codons that genetically encoded A34-containing tRNAs can recognise 20 .
In vitro transcribed human tRNA Ala AGC, a natural substrate of hetADAT, was incubated with purified human hetADAT. The reaction product was then reverse transcribed and amplified by PCR. Deamination was confirmed by sequencing the PCR amplicon, a commonly used strategy After cDNA synthesis, PCR amplification and digestion with Bpu1102l, samples were resolved in a 2% agarose gel. As expected, the full length amplicon is fully cleaved only when A34 is not modified.
To further characterize this method, we tested its sensitivity towards I34 detection and its potential to be used in a semi-quantitative manner. Fully modified-and fully unmodified-in vitro transcribed tRNA Ala AGC were mixed at known proportions. The levels of I34 modification were next evaluated by RFLP and the observed gel bands were quantified. Figure 4A tRNAs genetically encoded with A34 are known to be almost fully modified to I34 when fully matured 20, 26 . It was therefore surprising to observe a significant amount of amplicon cleavage for tRNA Ala AGC and tRNA Thr AGU in HeLa shCV cells ( Figure 6B and Supporting Information Figure S1D ). We sequenced the obtained amplicons for these samples and confirmed that A34 was present on both tRNAs (Supporting Information Figure S2) . After ruling out possible contamination of the PCR reaction with genomic DNA ( Figure 6B ) we concluded that part of the obtained amplicons were derived from unmodified precursor tRNA species. It is well known that RT of fully matured tRNAs is challenging and that in complex RNA samples, there is a bias towards reverse transcribing precursor tRNAs over mature tRNAs 19, [27] [28] [29] is only partially cleaved ( Figure 7A ). This is consistent with at least one of the aforementioned modifications inducing a detectable 'mutation' on the PCR amplicon. Of note, m 1 I37 has been reported to induce such a mutation as detected by RNAseq 15, 19 . To show the robustness of the method using in vivo tRNA samples, we performed three independent replicates for this experiment ( Figure 7B) . The results suggest that the RFLP method can detect other modifications besides inosine, although in this particular case it is not possible to determine the exact nature of the modification(s) (see Discussion section). and AvalI, consistent with partial tRNA modification on these regions ( Figure 8B and Figure 8C ). 
DISCUSSION
In recent years RNA modifications in tRNAs have emerged as a fundamental aspect of tRNA function and regulation, and highly relevant to human physiology 2, 3 . Moreover, while in the past ptRMs were considered rather static, mounting evidence now suggests that they can be dynamic 5, 6 . This prompts for the development of new techniques to efficiently detect, quantify, and monitor ptRMs. The RFLP method for ptRM detection can semi-quantitatively detect ptRMs on specific tRNA bases, and in different tRNA species. The method involves four steps: cDNA synthesis, PCR amplification with specific primers, digestion of the obtained amplicon with restriction endonucleases, and detection of cleavage patterns by gel electrophoresis (Figure 2) . Altogether, results can be obtained in less than 10 hours (see Step-by-step method description section).
We applied the RFLP method to evaluate the levels of ptRMs on in vitro transcribed tRNAs and on endogenous in vivo tRNA species. We show that, at least for I34 detection, the method can be used in a semi-quantitative manner, and has enough sensitivity to detect the modification even when it is present in only 1 % of the tRNA population (Figure 4) . We monitored A34-to-I34
editing by human hetADAT in vitro and under different reaction conditions using this approach, and showed that this method can be used to determine the optimal parameters for the deamination reaction ( Figure 5 ). It is likely that the RFLP method could also be useful to perform kinetic (time course) assays of hetADAT activity in vitro. We are currently performing a full in vitro characterization of hetADAT activity and we are hoping to shed light into this matter in the near future.
Two types of techniques are currently being used to detect ptRMs: LC-MS/MS and RNAseq.
The principal advantages of RNAseq over LC-MS/MS methods, are the fact that small amounts of RNA are required, and that detected ptRMs can be directly assigned to the tRNA sequence [15] [16] [17] [18] [19] [27] [28] [29] . The major drawback of RNAseq is that it often results in the detection of partially modified precursor tRNAs, rather than fully mature tRNAs 19, 27 .
In our analysis of I34 modifications on endogenous tRNAs, sequences from unmodified precursor tRNAs were also detected ( Figure 6B and Supporting Information Figure S2 ).
However, we were able to show that RFLP can be used to detect a relative decrease of I34 nucleotides in two tRNAs from HeLa cells when ADAT2 expression is silenced (Figure 6 and Supporting Information Figure S1D ). The partial downregulation of I34 levels in ADAT2 KD HeLa cells observed with the RFLP method was consistent with that reported in ADAT2 KD HEK293T cells using an RNAseq strategy 19 .
We also analyzed the potential of RFLP to detect other ptRMs in vivo. We intentionally focused on regions of tRNAs where several ptRMs might be present and have selected sites on tRNA Figure 8B and Figure   8C ) suggests that RFLP can also detect the m 7 G46 modification on this tRNA.
Finally, we also assessed the detection of m 1 I37, Ψ38 and Gm39 on tRNA Ala AGC by means of amplicon cleavage by SphI (Figure 7) . We detected partial amplicon cleavage of in vivo tRNA Ala AGC consistent with ptRM detection on at least one of these residues. Gm39 is known to be an RT-silent ptRM 7, 35 , therefore m 1 I37 is likely responsible for the observed partial cleavage of the PCR amplicon. We and others have previously shown that sequencing of m 1 I results mainly in A-to-T or A-to-G 'mutations' on PCR amplicons, and that such 'mutations' can be detected in amplicons derived from precursor tRNAs 15, 19 . Altogether, these results support the use of the RFLP method to detect, in vitro or in vivo, different ptRMs such as I, m 2 G, m 7 G and m 1 I in different tRNA species.
As mentioned above, the RFLP method for ptRM detection has some limitations. First, it requires the reverse transcription and amplification of the tRNA of interest. This is a significant problem for amplifying mature tRNAs, that may contain other ptRMs incompatible with RT reactions 7 . As discussed above, this may introduce a bias towards reverse transcribing partially modified precursor tRNAs over fully modified mature tRNAs. However, we believe that once the RT step is completed the PCR step of the RFLP method will not introduce additional biases (i.e.
the obtained cDNA template contains standard DNA bases). Despite this limitation, we show that it is possible to assess the modification status of tRNAs when the ptRM is incorporated at the precursor tRNA level, as it is the case for I34 and m 1 I37 (Figure 6B , Supporting Information Figure S1D , and Figure 7 ) 19 .
However, we note that the detected levels of ptRM under these conditions do not quantitatively represent the physiological levels of ptRMs on fully mature tRNAs. For example, in Figure 6B and Supporting Information Figure S1D , control cells showed ~10% of I34 modification on substrates expected to be ~100% modified when fully matured. Therefore, the RFLP method can accurately quantify the levels of ptRMs on in vitro tRNA substrates ( Obviously the RFLP method requires that the studied ptRM causes the incorporation of an alternative nucleotide on the reverse transcribed cDNA (e.g. Ψ could not be detected; Figure 8 ).
Here we have focused on four modifications that have this effect: m 2 G26, I34, m 1 I37 and m 7 G46.
Other ptRMs that share this property, and might be detected by RFLP, are cytidine deaminations (C-to-T), 1-methylguanosine (m 1 G) (G-to-T or C), 3-methylcytosine (m 3 C) (C-to-T or A), N2-N2-dimethylguanosine (m 2 2G) (G-to-A or T), N4-acetylcytidine (ac 4 C) (C-to-A), and N6-threonylcarbamoyladenosine (t 6 A) (A-to-C) 15-17, 25, 26, 36 .
Some of these ptRMs have been reported to cause hard-stops on RT, so they may not be easily detected by RFLP; as in the case for m 1 A58 modification (Figure 8) . However, it is important to note that the ptRM-mediated misincorporation of nucleotides during cDNA synthesis has been reported to be sequence context dependent 33, 36 ; therefore a comprehensive and systematic analysis of reverse transcriptase behavior when encountering ptRMs in a sequence context dependent manner is needed.
Finally, RFLP is limited by the need of a restriction enzyme that will differentially recognize the region of interest where ptRMs induce a change of sequence in their transcripts. In general, we have found useful restriction enzymes for most of our targets of interest. As an example, Table 1 gives an estimation of how frequently a restriction enzyme exists to identify A34-to-I34 conversion on tRNAs in different organisms. This limitation may be overcome with the advent of CRISPR/Cas9-based methods developed to facilitate the in vitro digestion of DNA at sites for which no endonuclease is available 37 .
Although RFLP is designed to evaluate the modification status of tRNA residues known (or suspected) to be modified (e.g. Figure 7 and Figure 8) , it can also be used as an initial screening step to detect new modification sites. In this case, we would recommend using as many restriction enzymes as possible to ensure a significant tRNA sequence coverage. Additionally, the selected restriction enzyme should recognize the unmodified residue and, if full cleavage is not observed, the presence of a modification can be suspected, and other independent means (e.g. LC-MS/MS using the purified specific tRNA type of interest) may be used to characterize it. Digested samples were then resolved in 2 % agarose gels or 15 % polyacrylamide gels (ran for 1 hour at 120 V). Similar results were obtained when using either gel type (Supporting Information Figure S1C ), but in some cases higher resolution may be achieved by PAGE. When required, gel bands were quantified using ImageJ. In our experience the full RFLP method for ptRM detection can be usually performed in less than 10 hours.
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